SC
NEO icon

Steven Cohen’s NeoGenomics NEO Stock Holding History

Steven Cohen’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,031,608
Closed -$14.3M – 2218
2024
Q2 		$14.3M Sell
1,031,608
-1,165,943
-53% -$16.5M 0.04% 497
2024
Q1 		$34.5M Buy
+2,197,551
New +$33.9M 0.08% 289
2023
Q4 		– Sell
-447,972
Closed -$5.51M – 2588
2023
Q3 		$5.51M Buy
447,972
+319,986
+250% +$4.76M 0.02% 852
2023
Q2 		$2.06M Buy
+127,986
New +$2.11M 0.01% 1035
2022
Q3 		– Sell
-2,075,433
Closed -$16.9M – 1633
2022
Q2 		$16.9M Buy
+2,075,433
New +$19.8M 0.07% 358
2019
Q3 		– Sell
-272,517
Closed -$5.98M – 1356
2019
Q2 		$5.98M Buy
+272,517
New +$5.98M 0.03% 475
2018
Q4 		– Sell
-29,142
Closed -$447K – 1132
2018
Q3 		$447K Buy
+29,142
New +$403K ﹤0.01% 934

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GF
Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Steven Cohen's NEO Position: Q3 2024 in Review

Steven Cohen sold out of NeoGenomics (NEO) in Q3 2024, closing a stake of 1,031,608 shares — an estimated $14.3M sold.

Steven Cohen first reported a position in NEO in Q3 2018 and held it in 7 quarters. The position peaked at $34.5M in Q1 2024. 270 funds tracked by Wall St. Rank hold NEO as of Q3 2024.

  • Steven Cohen reported no remaining NeoGenomics position as of Q3 2024 after selling out during the quarter.
  • Steven Cohen sold 1,031,608 NeoGenomics shares in Q3 2024, an estimated $14.3M.
  • Steven Cohen first reported a position in NeoGenomics in Q3 2018 and held it in 7 quarters.
  • Steven Cohen's NeoGenomics position peaked at $34.5M in Q1 2024.
  • 270 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2024.

Based on Point72 Asset Management's 13F filing for Q3 2024, filed 14 Nov 2024.